Poor
Not Aligned
Patient Risk:
Moderate
Summary
Several major claims rely on label sections that are not actually provided as excerpts in the prompt (cannot be verified), while many dosing/side-effect frequency and risk-framing claims are unsupported or unverifiable. Major label-safety areas (contraindications, boxed warnings, pregnancy/pediatrics) are not assessed, creating substantial noncompliance risk.
Category Scores
Accurate Statements
Lipitor works by inhibiting HMG-CoA reductase/cholesterol synthesis in the liver.
Supported by provided excerpt in 12.1 Mechanism of Action (inhibits HMG-CoA reductase and cholesterol synthesis in the liver).
Lipitor lowers LDL-cholesterol (LDL-C).
Supported by provided excerpt in 12.1 Mechanism of Action (reduces LDL-C).
Unsupported Statements
The right dosage of Lipitor will depend on factors including a patient's age, weight, and medical history.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
The typical starting dosage for Lipitor is 10-20 mg per day.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
The typical starting dosage for Lipitor is taken once daily.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
In some cases, a doctor may start Lipitor at a lower dosage and gradually increase it as needed.
Marked absent_from_the_label by the provided claim evaluation; not supported by provided excerpts.
Taking too little Lipitor may not be effective in lowering cholesterol levels.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
Common side effects of Lipitor include headache.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
Common side effects of Lipitor include nausea.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
Common side effects of Lipitor include diarrhea.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
Common side effects of Lipitor include stomach pain.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this.
Alternatives to Lipitor include Zocor (simvastatin).
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports listing specific alternatives.
Alternatives to Lipitor include Crestor (rosuvastatin).
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports listing specific alternatives.
Alternatives to Lipitor include Vytorin (ezetimibe/simvastatin).
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports listing specific alternatives.
Alternatives to Lipitor include Pravachol (pravastatin).
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports listing specific alternatives.
Lipitor is generally considered to be safe and effective.
Marked absent_from_the_label by the provided claim evaluation; no provided label excerpt supports this statement.
Long-term effects of Lipitor include increased risk of kidney damage.
Marked absent_from_the_label by the provided claim evaluation; provided excerpt only mentions acute renal failure secondary to rhabdomyolysis, not a long-term kidney damage risk.
Contradictions
Important Omissions
Contraindications section content was not evaluated (the evaluation includes no contraindication audit).
Importance:
High
Boxed warning status was not evaluated.
Importance:
High
Use in specific populations beyond the provided lactation excerpt (e.g., pregnancy, pediatrics) was not evaluated.
Importance:
High
Drug interaction claims (e.g., with CYP3A4 inhibitors/cyclosporine) were not assessed against provided label content.
Importance:
Moderate
Administration/storage instructions were not addressed (though not directly claimed, full label adherence audits typically require this review when dispensing guidance is discussed).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported/unverifiable dosing and 'common side effects' frequency claims could mislead about dose initiation, frequency, and expected adverse effects. The lack of evaluated contraindications/boxed warnings/pregnancy/pediatric information further increases safety audit noncompliance risk.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple critical claims are unsupported/absent from provided label excerpts, include unverifiable assertions (e.g., dosing ranges/frequency, 'common' adverse effects), and major safety label areas (contraindications/boxed warnings/pregnancy/pediatrics) were not audited.
Suggested Improvement
Restrict claims to verbatim-provided label excerpts; provide exact label text for every cited section and avoid frequency qualifiers and deterministic risk framing unless explicitly supported. Add audit coverage for contraindications, boxed warnings, pregnancy/lactation, pediatrics, and key drug interactions.